Suhas H. Mangoli

Involvement of Reactive Oxygen Species in the Action of Ciprofloxacin against Escherichia coli

ABSTRACT Ciprofloxacin is an important and commonly used member of the fluoroquinolone group of antibiotics. Ciprofloxacin inhibits DNA topoisomerase II and DNA topoisomerase IV activities, eventually leading to bacterial cell death. In addition, an increase of reactive oxygen species in the bacterial cells in response to ciprofloxacin has been shown. We investigated the role of reactive oxygen species in the antibacterial action of ciprofloxacin by studying the effects of different antioxidant compounds on ciprofloxacin susceptibility of Escherichia coli. Among the antioxidants checked, glutathione and ascorbic acid provided substantial protection against ciprofloxacin. The involvement of superoxide anion (O2−) and hydrogen peroxide (H2O2) in the antibacterial action of ciprofloxacin was analyzed using superoxide dismutase, catalase, and alkyl hydroperoxide reductase knockout strains of E. coli. The effects of multicopy sod genes on ciprofloxacin susceptibility of E. coli were also analyzed. On the basis of our results, we conclude that O2− and H2O2 may be involved in antibacterial action of ciprofloxacin. Our findings that glutathione gave protection against other fluoroquinolones and not against nonfluoroquinolone antibiotics imply that reactive oxygen species may have a similar role in the antibacterial action of all these fluoroquinolones and that glutathione-mediated protection is not a general phenomenon but specific to fluoroquinolones. These observations are of significance, as fluoroquinolones are important antibiotics with immense therapeutic value, and the effectiveness of treatment by these drugs may be affected by dietary intake and cellular levels of these antioxidants.

Involvement of a periplasmic protein kinase in DNA strand break repair and homologous recombination in Escherichia coli

The involvement of signal transduction in the repair of radiation‐induced damage to DNA has been known in eukaryotes but remains understudied in bacteria. This article for the first time demonstrates a role for the periplasmic lipoprotein (YfgL) with protein kinase activity transducing a signal for DNA strand break repair in Escherichia coli. Purified YfgL protein showed physical as well as functional interaction with pyrroloquinoline‐quinone in solution and the protein kinase activity of YfgL was strongly stimulated in the presence of pyrroloquinoline‐quinone. Transgenic E. coli cells producing Deinococcus radiodurans pyrroloquinoline‐quinone synthase showed nearly four log cycle improvement in UVC dark survival and 10‐fold increases in gamma radiation resistance as compared with untransformed cells. Pyrroloquinoline‐quinone enhanced the UV resistance of E. coli through the YfgL protein and required the active recombination repair proteins. The yfgL mutant showed higher sensitivity to UVC, mitomycin C and gamma radiation as compared with wild‐type cells and showed a strong impairment in homologous DNA recombination. The mutant expressing an active YfgL in trans recovered the lost phenotypes to nearly wild‐type levels. The results strongly suggest that the periplasmic phosphoquinolipoprotein kinase YfgL plays an important role in radiation‐induced DNA strand break repair and homologous recombination in E. coli.

Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.

ABSTRACT We examined the effects of antioxidants and the role of reactive oxygen species (ROS) on the antibacterial action of aminoglycosides in Escherichia coli. We concluded that reduced streptomycin sensitivity in the presence of glutathione and ascorbic acid is not due to the antioxidant-mediated scavenging of ROS.

Identification, mapping and characterization of two genes ofEscherichia coli K-12 regulating growth and resistance to streptomycin in cold

Escherichia coli MD1157, a routine isolate of AB1157 maintained in our laboratory, was noticed to have spontaneously acquired two conditional cold-dependent phenotypes: Cs (cold sensitivity) and Smsc (streptomycin sensitivity in cold). Cs involved delayed appearance of visible colonies on solid (LB or minimal) medium in cold (22° C or below) without any loss of viability, and an extended lag period and longer doubling time following a temperature downshift in liquid medium. Smsc involved conditional suppression of therpsL31 -mediated streptomycin (Sm) resistance in cold, resulting in reduced colony forming ability in the presence of Sm. This phenotype was seen only on LB plates and weakly on minimal-medium plates containing some LB, but not on minimal medium alone. Genetic mapping traced these two phenotypes to mutations in two genes mapping to the 14-15 min region of the standardE. coli map, which have been namedgicA (growth in cold) andgicB respectively. Comparison of MD1157 with transductants which had lost either one or both of these mutations showed that whilegicBl contributes only to Smsc,gicAl is associated with both Cs and Smsc. Comparison of these strains with AB1157 suggested the involvement of a third, as yet unidentified gene in causing these phenotypes.

Increased ultraviolet radiation sensitivity of Escherichia coli grown at low temperature.

The repair of DNA damage caused by ultraviolet radiation (UVR) is well understood in both lower and higher organisms. Genetic studies carried out at optimum temperature for growth, 37 °C in Escherichia coli, have revealed the major pathways of DNA repair. We show that E. coli cells grown at 20 °C are more sensitive to UVR than cells grown at 37 °C. The analysis of knockout mutants demonstrates that cells impaired in recombinational DNA repair pathways show increased UV sensitivity at 20 °C. Cells with mutations in the nucleotide excision repair (NER) pathway genes are highly sensitive to UVR when grown at 37 °C and retain that sensitivity when grown at 20 °C, whereas wild-type cells are not sensitive when grown at 37 °C but become more sensitive to UVR when grown at low temperatures. Our results taken along with reports from the literature suggest that the UVR sensitivity of E. coli cells at low temperature could be due to impaired NER function.

DNA damage is a late event in resveratrol-mediated inhibition of Escherichia coli.

ABSTRACT Resveratrol is an important phytoalexin notable for a wide variety of beneficial activities. Resveratrol has been reported to be active against various pathogenic bacteria. However, it is not clear at the molecular level how this important activity is manifested. Resveratrol has been reported to bind to cupric ions and reduce it. In the process, it generates copper-peroxide complex and reactive oxygen species (ROS). Due to this ability, resveratrol has been shown to cleave plasmid DNA in several studies. To this end, we envisaged DNA damage to play a role in resveratrol mediated inhibition in Escherichia coli. We employed DNA damage repair deficient mutants from keio collection to demonstrate the hypersensitive phenotype upon resveratrol treatment. Analysis of integrity and PCR efficiency of plasmid DNA from resveratrol-treated cells revealed significant DNA damage after 6 h or more compared to DNA from vehicle-treated cells. RAPD-PCR was performed to demonstrate the damage in genomic DNA from resveratrol-treated cells. In addition, in situ DNA damage was observed under fluorescence microscopy after resveratrol treatment. Further resveratrol treatment resulted in cell cycle arrest of significant fraction of population revealed by flow cytometry. However, a robust induction was not observed in phage induction assay and induction of DNA damage response genes quantified by promoter fused fluorescent tracker protein. These observations along with our previous observation that resveratrol induces membrane damage in E. coli at early time point reveal, DNA damage is a late event, occurring after a few hours of treatment.

A novel mutation spatially remote from the G-domain in IF2 affects the cold stress adaptation of Escherichia coli.

In this paper, we describe a new mutation, gicD1, that gives a cold-sensitive phenotype in bacterial cell growth. Complementation analysis showed gicD1 to be allelic to infB. We identify gicD1 to be a valine to isoleucine substitution in initiation factor-2 (IF2) of a residue that seems to be well conserved in eubacterial IF2 proteins. This mutation lies in a region distant from the G-domain to which all earlier reported cold-sensitive mutations cluster. We describe a novel phenotype of the mutant that is suppression of rpsL31-mediated streptomycin resistance in cold. We provide evidence that mutant IF2 specifically interacts with rpsL31 in cold, leading to a bacteriostatic effect on host cells.

Importance of chemical modification at C-7 position of quinolones for glutathione-mediated reversal of antibacterial activity

[1] Gelfand MS, Mazumder SA, Cleveland K. Minocycline for the treatment of community-acquired Staphylococcus aureus infections. Int J Antimicrob Agents 2014:43. [2] Cunha BA. Minocycline, often forgotten but preferred to trimethoprim– sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Int J Antimicrob Agents 2013;42:497–9. [3] Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers HF. Doxycycline, not minocycline, induces its own resistance in multidrugresistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis 2009;48:1483–4. [4] Cunha BA. Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness. Int J Antimicrob Agents 2010;35:517–8. [5] Cunha BA. Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 2005;11(Suppl. 4):33–42. [6] Ruhe JJ, Monson T, Bradsher RW, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005;40:1429–34. [7] Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillinresistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007;44: 777–84. [8] Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am 2006;90:1197–222. [9] Kucers A, (Editor). Kucers’ the Use of Antibiotics. etc. 5th ed. Oxford, UK: Butterworth Heinemann; 1997. pp. 719–63. 10] Cunha BA, editor. Antibiotic essentials. 12th ed. Sudbury, MA: Jones & Bartlett; 2013. pp. 8–16, 132–5, 595–7, 647–8, 680–2.